Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Clin Gastroenterol Hepatol. 2018 Jun;16(6):884-891.e1. doi: 10.1016/j.cgh.2017.05.051. Epub 2017 Jun 8.
BACKGROUND & AIMS: Colonic diverticulosis has been reported to be associated with low-grade mucosal inflammation, possibly leading to chronic gastrointestinal symptoms. However, there is poor evidence for this association. We aimed to determine mucosal inflammation and whether diverticula are associated with chronic gastrointestinal symptoms. We explored whether inflammation was present among symptomatic participants with and without diverticula.
We analyzed data from a prospective study of 619 patients undergoing a screening colonoscopy from 2013 through 2015 at the University of North Carolina Hospital in Chapel Hill, North Carolina. Among our participants, 255 (41%) had colonic diverticula. Colonic mucosal biopsy specimens were analyzed for levels of interleukin 6 (IL6), IL10, and tumor necrosis factor messenger RNAs by quantitative reverse-transcriptase polymerase chain reaction, and numbers of immune cells (CD4+, CD8+, CD57+, and mast cell tryptase) by immunohistochemistry. Gastrointestinal symptoms were assessed using Rome III criteria. Proportional odds models were used to estimate odds ratios (ORs) and 95% confidence interval (CIs).
After adjustment for potential confounders, there was no association between diverticulosis and tumor necrosis factor (OR, 0.85; 95% CI, 0.63-1.16), and no association with CD4+ cells (OR, 1.18; 95% CI, 0.87-1.60), CD8+ cells (OR, 0.97; 95% CI, 0.71-1.32), or CD57+ cells (OR, 0.80; 95% CI, 0.59-1.09). Compared with controls without diverticulosis, biopsy specimens from individuals with diverticulosis were less likely to express the inflammatory cytokine IL6 (OR, 0.59; 95% CI, 0.36-0.96). There was no association between diverticulosis and irritable bowel syndrome (OR, 0.53; 95% CI, 0.26-1.05) or chronic abdominal pain (OR, 0.68; 95% CI, 0.38-1.23). There was no evidence for inflammation in patients with symptoms when patients with vs without diverticulosis were compared.
We found no evidence that colonic diverticulosis is associated with mucosal inflammation or gastrointestinal symptoms. Among patients with symptoms and diverticula, we found no mucosal inflammation.
结肠憩室病与低度黏膜炎症有关,可能导致慢性胃肠道症状。然而,这种关联的证据不足。我们旨在确定黏膜炎症以及憩室是否与慢性胃肠道症状有关。我们探讨了有症状的参与者中是否存在憩室和无憩室的炎症。
我们分析了 2013 年至 2015 年期间在北卡罗来纳大学教堂山分校医院进行的一项前瞻性研究的 619 名患者的数据,这些患者接受了筛查性结肠镜检查。我们的参与者中有 255 名(41%)患有结肠憩室病。通过定量逆转录聚合酶链反应分析结肠黏膜活检标本中白细胞介素 6(IL6)、IL10 和肿瘤坏死因子信使 RNA 的水平,并通过免疫组织化学分析免疫细胞(CD4+、CD8+、CD57+和肥大细胞 tryptase)的数量。使用罗马 III 标准评估胃肠道症状。使用比例优势模型估计比值比(OR)和 95%置信区间(CI)。
在调整潜在混杂因素后,憩室病与肿瘤坏死因子之间没有关联(OR,0.85;95%CI,0.63-1.16),与 CD4+细胞(OR,1.18;95%CI,0.87-1.60)、CD8+细胞(OR,0.97;95%CI,0.71-1.32)或 CD57+细胞(OR,0.80;95%CI,0.59-1.09)也没有关联。与没有憩室病的对照组相比,有憩室病的个体的炎症细胞因子 IL6 表达水平较低(OR,0.59;95%CI,0.36-0.96)。憩室病与肠易激综合征(OR,0.53;95%CI,0.26-1.05)或慢性腹痛(OR,0.68;95%CI,0.38-1.23)之间没有关联。当比较有症状的患者与没有憩室病的患者时,没有证据表明存在炎症。
我们没有发现结肠憩室病与黏膜炎症或胃肠道症状有关的证据。在有症状和憩室病的患者中,我们没有发现黏膜炎症。